Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

55301 - 55310 of 57555 results found

Nocardia pseudobrasiliensis Co-infection in SARS-CoV-2 Patients

Date
Thursday, March 23, 2023 - 4:00 AM
Description
During the SARS-CoV-2 pandemic, few cases of Nocar-dia spp. co-infection have been reported during or after a COVID-19 infection. Nocardia spp. are gram-positive aerobic actinomycetes that stain partially acid-fast, can infect immunocompromised

Liver and Renal Injury with Remdesivir Treatment in SARS-CoV-2 Patients

Date
Thursday, March 23, 2023 - 4:00 AM
Description
CONCLUSION: Only three patients developed adverse effects resulting in stopping of Remdesivir, however these were reversible on stopping the drug. Therefore, Remdesivir is a relatively safe drug and well tolerated in SARS-CoV-2 patients.